Free Trial

Hellenic Dynamics (HELD) Competitors

Hellenic Dynamics logo
GBX 0.95 0.00 (0.00%)
(As of 11/19/2024 ET)

HELD vs. N4P, HLN, HIK, HCM, INDV, AMYT, AGY, APH, BXP, and ANCR

Should you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include N4 Pharma (N4P), Haleon (HLN), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Beximco Pharmaceuticals (BXP), and Animalcare Group (ANCR). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Hellenic Dynamics vs.

N4 Pharma (LON:N4P) and Hellenic Dynamics (LON:HELD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations, community ranking and media sentiment.

Hellenic Dynamics' return on equity of 0.00% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
N4 PharmaN/A -82.39% -56.00%
Hellenic Dynamics N/A N/A N/A

Hellenic Dynamics has lower revenue, but higher earnings than N4 Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
N4 Pharma£23.52K117.47-£1.08MN/AN/A
Hellenic DynamicsN/AN/AN/AN/AN/A

N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users.

CompanyUnderperformOutperform
N4 PharmaOutperform Votes
103
65.61%
Underperform Votes
54
34.39%
Hellenic DynamicsN/AN/A

In the previous week, Hellenic Dynamics had 1 more articles in the media than N4 Pharma. MarketBeat recorded 1 mentions for Hellenic Dynamics and 0 mentions for N4 Pharma. Hellenic Dynamics' average media sentiment score of 0.63 beat N4 Pharma's score of 0.00 indicating that Hellenic Dynamics is being referred to more favorably in the news media.

Company Overall Sentiment
N4 Pharma Neutral
Hellenic Dynamics Positive

0.1% of Hellenic Dynamics shares are held by institutional investors. 18.0% of N4 Pharma shares are held by company insiders. Comparatively, 72.9% of Hellenic Dynamics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Hellenic Dynamics beats N4 Pharma on 6 of the 8 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HELD vs. The Competition

MetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£1.40M£1.15B£5.10B£1.40B
Dividend YieldN/A3.13%5.04%11.79%
P/E RatioN/A109.9795.121,555.80
Price / SalesN/A1,897.431,217.30210,506.32
Price / CashN/A10.2639.4933.06
Price / BookN/A3.056.972.81
Net IncomeN/A£155.48M£118.73M£153.14M
7 Day PerformanceN/A-1.16%-1.22%-0.48%
1 Month PerformanceN/A-3.87%-3.07%7.21%
1 Year Performance-74.67%90.08%32.52%93.59%

Hellenic Dynamics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HELD
Hellenic Dynamics
N/AGBX 0.95
flat
N/A+2,433.3%£1.40MN/A0.00N/A
N4P
N4 Pharma
N/AGBX 0.70
+7.7%
N/A-19.1%£2.76M£23,524.00-55.005Gap Up
HLN
Haleon
1.2406 of 5 stars
GBX 368.54
0.0%
GBX 415
+12.6%
+13.2%£33.32B£11.26B3,071.6725,408
HIK
Hikma Pharmaceuticals
2.7912 of 5 stars
GBX 1,865.99
+1.1%
GBX 2,383.33
+27.7%
+5.3%£4.14B£3.02B2,860.009,100
HCM
HUTCHMED
N/AGBX 281
-1.1%
N/A-4.7%£2.40B£610.81M-7,100.001,760Positive News
INDV
Indivior
2.1487 of 5 stars
GBX 837
+1.3%
GBX 1,500
+79.2%
-38.8%£1.08B£1.15B-1,033.131,000High Trading Volume
AMYT
Amryt Pharma
N/AGBX 143
-11.7%
N/A+0.0%£457.11M£210.24M-4.33290Gap Down
AGY
Allergy Therapeutics
N/AGBX 5.20
-5.5%
N/A+205.6%£248.04M£53.26M-91.67612Gap Down
APH
Alliance Pharma
2.5903 of 5 stars
GBX 44.50
+0.5%
GBX 60
+34.8%
+16.6%£240.55M£183.15M-745.8391,000
BXP
Beximco Pharmaceuticals
N/AGBX 34
+4.6%
N/A-24.4%£151.68M£43.08B425.005,500Gap Up
ANCR
Animalcare Group
N/AGBX 244
-2.0%
N/A+41.6%£147.30M£76.10M3,086.25220News Coverage

Related Companies and Tools


This page (LON:HELD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners